For best viewing of the website please use Mozilla Firefox or Google Chrome.
Serving the Society Since 1986
Advanced Search
    Citation: Yue Yin, Herman W. Favoreel. Herpesviruses and the Type Ⅲ Interferon System [J].VIROLOGICA SINICA.  http://dx.doi.org/10.1007/s12250-020-00330-2
    shu

    Herpesviruses and the Type Ⅲ Interferon System

    • 1.

      Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium

    • Corresponding author: Herman W. Favoreel, herman.favoreel@ugent.be, ORCID: 0000-0003-4993-6857
    • Received Date: 09 September 2020
      Accepted Date: 27 October 2020
      Published Date: 05 January 2021
    • Type Ⅲ interferons (IFNs) represent the most recently discovered group of IFNs. Together with type Ⅰ IFNs (e.g. IFN-α/β), type Ⅲ IFNs (IFN-λ) are produced as part of the innate immune response to virus infection, and elicit an anti-viral state by inducing expression of interferon stimulated genes (ISGs). It was initially thought that type Ⅰ IFNs and type Ⅲ IFNs perform largely redundant functions. However, it has become evident that type Ⅲ IFNs particularly play a major role in antiviral protection of mucosal epithelial barriers, thereby serving an important role in the first-line defense against virus infection and invasion at contact areas with the outside world, versus the generally more broad, potent and systemic antiviral effects of type Ⅰ IFNs. Herpesviruseses are large DNA viruses, which enter their host via mucosal surfaces and establish lifelong, latent infections. Despite the importance of mucosal epithelial cells in the pathogenesis of herpesviruses, our current knowledge on the interaction of herpesviruses with type Ⅲ IFN is limited and largely restricted to studies on the alphaherpesvirus herpes simplex virus (HSV). This review summarizes the current understanding about the role of IFN-λ in the immune response against herpesvirus infections.
    • 加载中

      1. Albà MM, Das R, Orengo CA, Kellam P (2001) Genomewide function conservation and phylogeny in the Herpesviridae. Genome Res 11:43–54
          doi: 10.1101/gr.149801

      2. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR (2006) Lambda interferon (IFN-λ), a type Ⅲ IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80:4501–4509
          doi: 10.1128/JVI.80.9.4501-4509.2006

      3. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H (2008) An important role for type Ⅲ interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J Immunol 180:2474–2485
          doi: 10.4049/jimmunol.180.4.2474

      4. Arslan M, Yang X, Santhakumar D, Liu X, Hu X, Munir M, Li Y, Zhang Z (2019) Dynamic expression of interferon lambda regulated genes in primary fibroblasts and immune organs of the chicken. Genes 10:145
          doi: 10.3390/genes10020145

      5. Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (2007) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge

      6. Berry R, Watson GM, Jonjic S, Degli-Esposti MA, Rossjohn J (2020) Modulation of innate and adaptive immunity by cytomegaloviruses. Nat Rev Immunol 20:113–127
          doi: 10.1038/s41577-019-0225-5

      7. Bibert S, Wojtowicz A, Taffé P, Manuel O, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Kaiser L, Osthoff M (2014) The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. Aids 28:1885–1889
          doi: 10.1097/QAD.0000000000000379

      8. Bilichodmath S, Nair SK, Bilichodmath R, Mangalekar SB (2018) mRNA expression of IFN-λs in the gingival tissue of patients with chronic or aggressive periodontitis: a polymerase chain reaction study. J Periodontol 89:867–874
          doi: 10.1002/JPER.17-0349

      9. Bin L, Li X, Richers B, Streib JE, Hu JW, Taylor P, Leung DY (2018) Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum. J Allergy Clin Immunol 141(2085–2093):e2081
          doi: 10.1016/j.jaci.2018.01.001

      10. Blumer T, Coto-Llerena M, Duong FH, Heim MH (2017) SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)–induced gene expression in vivo. J Biol Chem 292:17928–17938
          doi: 10.1074/jbc.M117.788877

      11. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte J-M, Diebold J, Diepolder H, Adler B, Auernhammer CJ (2005) IL-28A and IL-29 Mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic expression. Am J Physiol Gastrointest Liver Physiol 289:960–968
          doi: 10.1152/ajpgi.00126.2005

      12. Bravo D, Solano C, Giménez E, Remigia MJ, Corrales I, Amat P, Navarro D (2014) Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients. J Med Virol 86:838–844
          doi: 10.1002/jmv.23865

      13. Chen S, Zhang W, Zhou Q, Wang A, Sun L, Wang M, Jia R, Zhu D, Liu M, Sun K (2017) Cross-species antiviral activity of goose interferon lambda against duck plague virus is related to its positive self-regulatory feedback loop. J Gen Virol 98:1455–1466
          doi: 10.1099/jgv.0.000788

      14. Costa AS, Agostini S, Guerini FR, Mancuso R, Zanzottera M, Ripamonti E, Racca V, Nemni R, Clerici M (2017) Modulation of immune responses to herpes simplex virus type 1 by IFNL3 and IRF7 polymorphisms: a study in Alzheimer's disease. J Alzheimer's Dis 60:1055–1063
          doi: 10.3233/JAD-170520

      15. Dağ F, Dölken L, Holzki J, Drabig A, Weingärtner A, Schwerk J, Lienenklaus S, Conte I, Geffers R, Davenport C (2014) Reversible silencing of cytomegalovirus genomes by type i interferon governs virus latency. PLoS Pathog 10:e1003962
          doi: 10.1371/journal.ppat.1003962

      16. Danastas K, Miranda-Saksena M, Cunningham AL (2020) Herpes Simplex Virus Type 1 Interactions with the Interferon System. Int J Mol Sci 21:5150
          doi: 10.3390/ijms21145150

      17. De Pelsmaeker S, Romero N, Vitale M, Favoreel HW (2018) Herpesvirus evasion of natural killer cells. J Virol 92:e2105–e2117

      18. De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW (2010) Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PloS one 5:e13076
          doi: 10.1371/journal.pone.0013076

      19. Ding S, Khoury-Hanold W, Iwasaki A, Robek MD (2014) Epigenetic reprogramming of the type Ⅲ interferon response potentiates antiviral activity and suppresses tumor growth. PLoS Biol 12:e1001758
          doi: 10.1371/journal.pbio.1001758

      20. Donnelly RP, Kotenko SV (2010) Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res 30:555–564
          doi: 10.1089/jir.2010.0078

      21. Egli A, Levin A, Santer DM, Joyce M, O'Shea D, Thomas BS, Lisboa LF, Barakat K, Bhat R, Fischer KP (2014) Immunomodulatory function of interleukin 28B during primary infection with cytomegalovirus. J Infect Dis 210:717–727
          doi: 10.1093/infdis/jiu144

      22. Enquist LW, Leib DA (2017) Intrinsic and innate defenses of neurons: Detente with the herpesviruses. J Virol 91

      23. Fan W, Xie S, Zhao X, Li N, Chang C, Li L, Yu G, Chi X, Pan Y, Niu J (2016) IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis c through long-term induction of USP18. J Gen Virol 97:2210–2220
          doi: 10.1099/jgv.0.000522

      24. Fernández-Ruiz M, Corrales I, Amat P, González E, Andrés A, Navarro D, Aguado J (2015) Influence of age and HLA Alleles on the CMV-specific cell-mediated immunity among CMV-seropositive kidney transplant candidates. Am J Transplant Off J Am Soc Transplante Am Soc Transplant Surg 15:2525–2526
          doi: 10.1111/ajt.13370

      25. Fuld S, Cunningham C, Klucher K, Davison AJ, Blackbourn DJ (2006) Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 80:3092–3097
          doi: 10.1128/JVI.80.6.3092-3097.2006

      26. García-Sastre A (2017) Ten strategies of interferon evasion by viruses. Cell Host Microbe 22:176–184
          doi: 10.1016/j.chom.2017.07.012

      27. Gimeno Brias S, Marsden M, Forbester J, Clement M, Brandt C, Harcourt K, Kane L, Chapman L, Clare S, Humphreys IR (2018) Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection. PLoS ONE 13:e0197596
          doi: 10.1371/journal.pone.0197596

      28. Gonzalez-Perez AC, Stempel M, Chan B, Brinkmann MM (2020) One step ahead: herpesviruses Light the Way to Understanding Interferon-Stimulated Genes (ISGs). Front Microbiol 11:124
          doi: 10.3389/fmicb.2020.00124

      29. Griffiths SJ, Koegl M, Boutell C, Zenner HL, Crump CM, Pica F, Gonzalez O, Friedel CC, Barry G, Martin K (2013) A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication. PLoS Pathog 9:e1003514
          doi: 10.1371/journal.ppat.1003514

      30. Grinde B (2013) Herpesviruses: latency and reactivation–viral strategies and host response. J Oral Microbiol 5:22766
          doi: 10.3402/jom.v5i0.22766

      31. Huang M, Jiang J-D, Peng Z (2014) Recent advances in the anti-HCV mechanisms of interferon. Acta Pharmaceutica Sinica B 4:241–247
          doi: 10.1016/j.apsb.2014.06.010

      32. Iversen MB, Ank N, Melchjorsen J, Paludan SR (2010) Expression of type Ⅲ interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-κB than type Ⅰ IFNs. J Virol 84:4579–4586
          doi: 10.1128/JVI.02591-09

      33. Jacobs S, Zeippen C, Wavreil F, Gillet L, Michiels T (2019) IFN-λ Decreases Murid Herpesvirus-4 infection of the olfactory epithelium but fails to prevent virus reactivation in the vaginal mucosa. Viruses 11:757
          doi: 10.3390/v11080757

      34. Jahanban-Esfahlan R, Seidi K, Majidinia M, Karimian A, Yousefi B, Nabavi SM, Astani A, Berindan-Neagoe I, Gulei D, Fallarino F (2019) Toll-like receptors as novel therapeutic targets for herpes simplex virus infection. Rev Med Virol 29:e2048
          doi: 10.1002/rmv.2048

      35. Jayanthi D, Faizuddin M, Noor Ahamadi H (2017) Association of interferon lambda-1 with herpes simplex viruses-1 and-2, Epstein-Barr virus, and human cytomegalovirus in chronic periodontitis. J Investig Clin Dent 8:e12200
          doi: 10.1111/jicd.12200

      36. Johnston C, Gottlieb SL, Wald A (2016) Status of vaccine research and development of vaccines for herpes simplex virus. Vaccine 34:2948–2952
          doi: 10.1016/j.vaccine.2015.12.076

      37. Jones C (2019) Bovine herpesvirus 1 counteracts immune responses and immune-surveillance to enhance pathogenesis and virus transmission. Front Immunol 10:1008
          doi: 10.3389/fimmu.2019.01008

      38. Karpala AJ, Morris KR, Broadway MM, McWaters PG, O'Neil TE, Goossens KE, Lowenthal JW, Bean AG (2008) Molecular cloning, expression, and characterization of chicken IFN-λ. J Interferon Cytokine Res 28:341–350
          doi: 10.1089/jir.2007.0117

      39. Kim J-A, Park S-K, Seo S-W, Lee C-H, Shin OS (2017) STING is involved in antiviral immune response against VZV infection via the induction of type Ⅰ and Ⅲ IFN pathways. J Investig Dermatol 137:2101–2109
          doi: 10.1016/j.jid.2017.03.041

      40. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP (2003) IFN-λs mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex. Nat Immunol 4:69–77

      41. Koyuncu OO, MacGibeny MA, Enquist LW (2018) Latent versus productive infection: The alpha herpesvirus switch. Future Virol 13:431–443
          doi: 10.2217/fvl-2018-0023

      42. Kuhs KAL, Kuniholm MH, Pfeiffer RM, Chen S, Desai S, Edlin BR, Peters MG, Plankey M, Sharp GB, Strickler HD (2015) Interferon lambda 4 genotype is not associated with recurrence of oral or genital herpes. PLoS ONE 10:e0138827
          doi: 10.1371/journal.pone.0138827

      43. La Rosa F, Agostini S, Bianchi A, Nemni R, Piancone F, Marventano I, Mancuso R, Saresella M, Clerici M (2019) Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients. J Translat Med 17:286
          doi: 10.1186/s12967-019-2034-9

      44. Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, Nischalke HD, Nattermann J, Oldenburg J, Sauerbruch T, Spengler U (2011) Interferon-lambda serum levels in hepatitis C. J Hepatol 54:859–865
          doi: 10.1016/j.jhep.2010.08.020

      45. Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, Freudenberg MA, Davey GM, Vremec D, Kallies A (2010) Mouse CD8α+DCs and human BDCA3+DCs are major producers of IFN-λ in response to poly IC. J Exp Med 207:2703–2717
          doi: 10.1084/jem.20092720

      46. Li J, Hu S, Zhou L, Ye L, Wang X, Ho J, Ho W (2011) Interferon lambda inhibits herpes simplex virus type Ⅰ infection of human astrocytes and neurons. Glia 59:58–67
          doi: 10.1002/glia.21076

      47. Li J, Ye L, Wang X, Hu S, Ho W (2012) Induction of interferon-λ contributes to toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes. J Neurosci Res 90:399–406
          doi: 10.1002/jnr.22758

      48. Li Z, Lu X, Zhu Y, Cheng P, Liu S, Zhang Y, Tang J, Yang S, Zhou L (2017) Lambda-interferons inhibit herpes simplex virus type 2 replication in human cervical epithelial cells through activation of JAK/STAT pathway. Jpn J Infect Dis JJID 2016:2465
          doi: 10.7883/yoken.JJID.2016.465

      49. Linderman JA, Kobayashi M, Rayannavar V, Fak JJ, Darnell RB, Chao MV, Wilson AC, Mohr I (2017) Immune escape via a transient gene expression program enables productive replication of a latent pathogen. Cell Rep 18:1312–1323
          doi: 10.1016/j.celrep.2017.01.017

      50. Liu F, Liu C, Hu X, Shang Y, Wu L (2017) MicroRNA-21: a positive regulator for optimal production of type Ⅰ and type Ⅲ interferon by plasmacytoid dendritic cells. Front Immunol 8:947
          doi: 10.3389/fimmu.2017.00947

      51. Liu Q, Rao Y, Tian M, Zhang S, Feng P (2019) Modulation of innate immune signaling pathways by herpesviruses. Viruses 11:572
          doi: 10.3390/v11060572

      52. Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM (2015) Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE 10:e0140765
          doi: 10.1371/journal.pone.0140765

      53. Lopušná K, Režuchová I, Kabat P, Kúdelová M (2014) Interferon lambda induces antiviral response to herpes simplex virus 1 infection. Acta Virol 58:325–332
          doi: 10.4149/av_2014_03_325

      54. Lopušná K, Benkóczka T, Lupták J, Matúšková R, Lukáčiková L', Ovečková I, Režuchová I (2016) Murine gammaherpesvirus targets type Ⅰ IFN receptor but not type Ⅲ IFN receptor early in infection. Cytokine 83:158–170
          doi: 10.1016/j.cyto.2016.04.013

      55. Manuel O, Wójtowicz A, Bibert S, Mueller NJ, Van Delden C, Hirsch HH, Steiger J, Stern M, Egli A, Garzoni C (2015) Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis 211:906–914
          doi: 10.1093/infdis/jiu557

      56. Megjugorac NJ, Gallagher GE, Gallagher G (2009) Modulation of human plasmacytoid DC function by IFN-λ1 (IL-29). J Leukoc Biol 86:1359–1363
          doi: 10.1189/jlb.0509347

      57. Megjugorac NJ, Gallagher GE, Gallagher G (2010) IL-4 enhances IFN-λ1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra. Blood J Am Soc Hematol 115:4185–4190
          doi: 10.1182/blood-2009-09-246157

      58. Melchjorsen J, Siren J, Julkunen I, Paludan SR, Matikainen S (2006) Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-κB and IRF-3. J Gen Virol 87:1099–1108
          doi: 10.1099/vir.0.81541-0

      59. Melchjorsen J, Rintahaka J, Søby S, Horan KA, Poltajainen A, Østergaard L, Paludan SR, Matikainen S (2010) Early innate recognition of herpes simplex virus in human primary macrophages is mediated via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase Ⅲ-independent pathways. J Virol 84:11350–11358
          doi: 10.1128/JVI.01106-10

      60. Murray MJ, Peters NE, Reeves MB (2018) Navigating the host cell response during entry into sites of latent cytomegalovirus infection. Pathogens 7:30
          doi: 10.3390/pathogens7010030

      61. Nordström I, Eriksson K (2012) HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9. PLoS ONE 7:e38683
          doi: 10.1371/journal.pone.0038683

      62. Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, Boulant S, Gehrke L, Cossart P, Kagan JC (2014) Diverse intracellular pathogens activate type Ⅲ interferon expression from peroxisomes. Nat Immunol 15:717
          doi: 10.1038/ni.2915

      63. Onabajo OO, Muchmore B, Prokunina-Olsson L (2019) The IFN-λ4 conundrum: when a good interferon goes bad. J Interferon Cytokine Res 39:636–641
          doi: 10.1089/jir.2019.0044

      64. Paquin A, Onabajo OO, Tang W, Prokunina-Olsson L (2016) Comparative functional analysis of 12 mammalian IFN-λ4 orthologs. J Interferon Cytokine Res 36:30–36
          doi: 10.1089/jir.2015.0096

      65. Pica F, Volpi A, Gaziano R, Garaci E (2010) Interferon-λ in immunocompetent individuals with a history of recurrent herpes labialis. Antiviral Therapy 15:737
          doi: 10.3851/IMP1610

      66. Pontejo SM, Murphy PM, Pease JE (2018) Chemokine subversion by human herpesviruses. J Innate Immun 10:465–478
          doi: 10.1159/000492161

      67. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164–171
          doi: 10.1038/ng.2521

      68. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J (2003) IL-28, IL-29 and their class Ⅱ cytokine receptor IL-28R. Nat Immunol 4:63–68
          doi: 10.1038/ni873

      69. Song R, Koyuncu OO, Greco TM, Diner BA, Cristea IM, Enquist LW (2016) Two modes of the axonal interferon response limit alphaherpesvirus neuroinvasion. mBio 7:e02145–15
          doi: 10.1128/mBio.02145-15

      70. Sorgeloos F, Kreit M, Hermant P, Lardinois C, Michiels T (2013) Antiviral type ⅰ and type ⅲ interferon responses in the central nervous system. Viruses 5:834–857
          doi: 10.3390/v5030834

      71. Steed AL, Barton ES, Tibbetts SA, Popkin DL, Lutzke ML, Rochford R, Virgin HW (2006) Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol 80:192–200
          doi: 10.1128/JVI.80.1.192-200.2006

      72. Su C, Zhan G, Zheng C (2016) Evasion of host antiviral innate immunity by HSV-1, an update. Virol J 13:1–9
          doi: 10.1186/s12985-015-0456-4

      73. Sun C, Luecke S, Bodda C, Jønsson KL, Cai Y, Zhang B-C, Jensen SB, Nordentoft I, Jensen JM, Jakobsen MR (2019) Cellular requirements for sensing and elimination of incoming HSV-1 DNA and capsids. J Interferon Cytokine Res 39:191–204
          doi: 10.1089/jir.2018.0141

      74. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'hUigin C, Kidd J, Kidd K, Khakoo SI, Alexander G (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798–801
          doi: 10.1038/nature08463

      75. Thomson SJ, Goh FG, Banks H, Krausgruber T, Kotenko SV, Foxwell BM, Udalova IA (2009) The role of transposable elements in the regulation of IFN-λ1 gene expression. Proc Natl Acad Sci 106:11564–11569
          doi: 10.1073/pnas.0904477106

      76. Tognarelli EI, Palomino TF, Corrales N, Bueno SM, Kalergis AM, González PA (2019) Herpes simplex virus evasion of early host antiviral responses. Front Cellular Infect Microbiol 9:127
          doi: 10.3389/fcimb.2019.00127

      77. Wells AI, Coyne CB (2018) Type Ⅲ interferons in antiviral defenses at barrier surfaces. Trends Immunol 39:848–858
          doi: 10.1016/j.it.2018.08.008

      78. Ye L, Schnepf D, Staeheli P (2019) Interferon-λ orchestrates innate and adaptive mucosal immune responses. Nat Rev Immunol 19:614–625
          doi: 10.1038/s41577-019-0182-z

      79. Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, Lewis-Antes A, Amrute SB, Garrigues U, Doyle S (2012) Type Ⅲ IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol 189:2735–2745
          doi: 10.4049/jimmunol.1102038

      80. Zanoni I, Granucci F, Broggi A (2017) Interferon (IFN)-λ takes the helm: immunomodulatory roles of type Ⅲ IFNs. Front Immunol 8:1661
          doi: 10.3389/fimmu.2017.01661

      81. Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–1527
          doi: 10.1126/science.1139522

      82. Zhang S-Q, Zhang Z, Luo X, Yang S, Chai Y, Huang H-L, Yin X-Y, Hu D-J, Yang C-J, Liu J-L (2011) Interleukin 29 enhances expression of Toll receptor 3 and mediates antiviral signals in human keratinocytes. Inflamm Res 60:1031
          doi: 10.1007/s00011-011-0364-z

      83. Zhang S-Y, Abel L, Casanova J-L (2013) Mendelian predisposition to herpes simplex encephalitis. In: Handbook of Clinical Neurology, vol 112. Elsevier, pp 1091–1097.

      84. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R (2007) Type Ⅲ interferon (IFN) induces a type Ⅰ IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 81:7749–7758
          doi: 10.1128/JVI.02438-06

      85. Zhou L, Li J, Wang X, Ye L, Hou W, Ho J, Li H, Ho W (2011) IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons. J Neurovirol 17:212–219
          doi: 10.1007/s13365-011-0031-8

      86. Zhou L, Li J-L, Zhou Y, Liu J-B, Zhuang K, Gao J-F, Liu S, Sang M, Wu J-G, Ho W-Z (2015) Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells. Mhr Basic Sci Reprod Med 21:917–929
          doi: 10.1093/molehr/gav058

      87. Zhou Y, Wang Z, Xu Y, Zhang Z, Hua R, Liu W, Jiang C, Chen Y, Yang W, Kong W (2017) Optimized DNA vaccine enhanced by adjuvant IL28B induces protective immune responses against herpes simplex virus type 2 in mice. Viral Immunol 30:601–614
          doi: 10.1089/vim.2017.0033

    • 加载中